| Dr Amy Safadi, MD | |
|
8081 Innovation Park Dr # 900, Fairfax, VA 22031-4867 | |
| (571) 472-4200 | |
| (571) 472-4201 |
| Full Name | Dr Amy Safadi |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Neurology |
| Location | 8081 Innovation Park Dr # 900, Fairfax, Virginia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013412436 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 0101274158 (Virginia) | Primary |
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952320061 PECOS PAC ID: 2466351093 Enrollment ID: O20080806000696 |
News Archive
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
As India reports record high daily covid-19 cases and deaths, a group of leading doctors say India must stop mass gatherings and consider postponing its forthcoming elections.
A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.
› Verified 4 days ago
| Entity Name | Inova Health Care Services |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1538870191 PECOS PAC ID: 2466351093 Enrollment ID: O20230130001570 |
News Archive
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
As India reports record high daily covid-19 cases and deaths, a group of leading doctors say India must stop mass gatherings and consider postponing its forthcoming elections.
A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Amy Safadi, MD 8081 Innovation Park Dr # 900, Fairfax, VA 22031-4867 Ph: (571) 472-4200 | Dr Amy Safadi, MD 8081 Innovation Park Dr # 900, Fairfax, VA 22031-4867 Ph: (571) 472-4200 |
News Archive
TARSA Therapeutics, Inc. today announced that its New Drug Application (NDA) for TBRIATM (calcitonin-salmon [rDNA origin] delayed release tablets) submitted to the U.S. Food and Drug Administration (FDA) in July 2015, has been accepted for review, with a PDUFA date of May 30, 2016.
As India reports record high daily covid-19 cases and deaths, a group of leading doctors say India must stop mass gatherings and consider postponing its forthcoming elections.
A team of Toronto-based researchers may be one step closer to a 'recipe' for large-scale production of stem cells for use in research and therapy.
The pathogenesis of chronic hepatitis C is associated with severe oxidative stress and non-selective immunological disturbance that lead to necroinflammation and the progression of fibrosis. Several trials have suggested that antioxidant and immunostimulant therapies may have a beneficial effect. Two previous clinical studies have reported that the Viusid related effect on histologic features, especially fibrosis, appears to be associated with antioxidant and/or immunomodulatory properties.
› Verified 4 days ago
Laura Anne Cinski, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr Ste 900, Fairfax, VA 22031 Phone: 571-472-4200 Fax: 571-472-4201 | |
Dr. Ashley Chorath, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 8221 Willow Oaks Corporate Dr # 425, Fairfax, VA 22031 Phone: 703-289-7599 | |
Dr. Anjuli Sara Jindal, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8221 Willow Oaks Corporate Dr, Fairfax, VA 22031 Phone: 703-207-7742 | |
Muhammad Taimoor Khan, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8081 Innovation Park Dr Ste 900, Fairfax, VA 22031 Phone: 571-472-4200 Fax: 571-472-4201 | |
Dr. Ravinderpal Singh, M.D, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 11204 Waples Mill Rd, Fairfax, VA 22030 Phone: 703-218-8500 Fax: 703-359-0463 | |
Dr. Siddharth Bajpai, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 8500 Executive Park Ave, Ste 200, Fairfax, VA 22031 Phone: 319-356-1616 Fax: 703-573-2351 |